Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomasz Burzykowski

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
Biometrical Journal. Biometrische Zeitschrift|February 3, 2006
A version of the EM algorithm for proportional hazard model with random effectsJosé Cortiñas Abrahantes, Tomasz Burzykowski
Pharmaceutical Statistics|August 4, 2021
Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpointsVaiva Deltuvaite-Thomas, Tomasz Burzykowski
Applied Bioinformatics|August 23, 2006
The use of background signal in the transformation of cDNA-microarray measurementsSuzy Van Sanden, Tomasz Burzykowski
Clinical Trials (London, England)|November 24, 2020
Bayesian biomarker-driven outcome-adaptive randomization with an imperfect biomarker assayLeandro Garcia Barrado, Tomasz Burzykowski
Clinical Trials (London, England)|February 21, 2023
Over-accrual in Bayesian adaptive trials with continuous futility stoppingLeandro Garcia Barrado, Tomasz Burzykowski
Pharmaceutical Statistics|June 5, 2024
Using an early outcome as the sole source of information of interim decisions regarding treatment effect on a long-term endpoint: The non-Gaussian caseLeandro Garcia Barrado, Tomasz Burzykowski
Rapid Communications in Mass Spectrometry : RCM|July 9, 2021
Predicting the number of sulfur atoms in peptides and small proteins based on the observed aggregated isotope distributionJürgen Claesen, Dirk Valkenborg, Tomasz Burzykowski
Methods in Molecular Biology (Clifton, N.J.)|April 14, 2019
Experimental Design in Quantitative ProteomicsTomasz Burzykowski, Jürgen Claesen, Dirk Valkenborg
International Journal of Clinical Oncology|August 3, 2015
Data-driven risk identification in phase III clinical trials using central statistical monitoringCatherine Timmermans, David Venet, Tomasz Burzykowski
Journal of the American Society for Mass Spectrometry|September 4, 2020
A "Refined Hydrogen Rule" and a "Refined Hydrogen and Halogen Rule" for Organic MoleculesJürgen Claesen, Dirk Valkenborg, Tomasz Burzykowski
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Biometrical Journal. Biometrische Zeitschrift|February 3, 2006
A version of the EM algorithm for proportional hazard model with random effectsJosé Cortiñas Abrahantes, Tomasz Burzykowski
Pharmaceutical Statistics|August 4, 2021
Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpointsVaiva Deltuvaite-Thomas, Tomasz Burzykowski
Applied Bioinformatics|August 23, 2006
The use of background signal in the transformation of cDNA-microarray measurementsSuzy Van Sanden, Tomasz Burzykowski
Clinical Trials (London, England)|November 24, 2020
Bayesian biomarker-driven outcome-adaptive randomization with an imperfect biomarker assayLeandro Garcia Barrado, Tomasz Burzykowski
Clinical Trials (London, England)|February 21, 2023
Over-accrual in Bayesian adaptive trials with continuous futility stoppingLeandro Garcia Barrado, Tomasz Burzykowski
Pharmaceutical Statistics|June 5, 2024
Using an early outcome as the sole source of information of interim decisions regarding treatment effect on a long-term endpoint: The non-Gaussian caseLeandro Garcia Barrado, Tomasz Burzykowski
Rapid Communications in Mass Spectrometry : RCM|July 9, 2021
Predicting the number of sulfur atoms in peptides and small proteins based on the observed aggregated isotope distributionJürgen Claesen, Dirk Valkenborg, Tomasz Burzykowski
Methods in Molecular Biology (Clifton, N.J.)|April 14, 2019
Experimental Design in Quantitative ProteomicsTomasz Burzykowski, Jürgen Claesen, Dirk Valkenborg
International Journal of Clinical Oncology|August 3, 2015
Data-driven risk identification in phase III clinical trials using central statistical monitoringCatherine Timmermans, David Venet, Tomasz Burzykowski
Journal of the American Society for Mass Spectrometry|September 4, 2020
A "Refined Hydrogen Rule" and a "Refined Hydrogen and Halogen Rule" for Organic MoleculesJürgen Claesen, Dirk Valkenborg, Tomasz Burzykowski
Pageof 15